Editors' ChoiceCancer

RNase moonlights as a cancer instigator

See allHide authors and affiliations

Science Translational Medicine  11 Apr 2018:
Vol. 10, Issue 436, eaat3892
DOI: 10.1126/scitranslmed.aat3892


RNase 5 is a bona fide EGFR ligand that promotes oncogenic transformation in pancreatic cancer.

View Full Text

Stay Connected to Science Translational Medicine